Tifani Anton

AbbVie (United States)

Papers

2

Total Citations

12

H-Index

2

About

Tifani Anton is a rising leader in functional genomics, whose work is transforming the precision and scalability of CRISPR-based genetic screens. Her primary research focuses on optimizing loss-of-function (LOF) screening technologies, with a particular emphasis on overcoming the limitations of conventional CRISPR-Cas9 libraries. Anton’s major contribution lies in her pioneering use of AsCas12a and multi-guide arrays to dramatically enhance the efficiency and accuracy of genomewide screens. Her most-cited paper (2023, 10 citations) details a novel optimization strategy that reduces off-target effects and improves gene knockout coverage, enabling more robust discovery of gene functions in complex physiological and disease systems. This work has already garnered attention for its potential to accelerate target identification in drug development and basic biology. By refining the tools for systematic gene interrogation, Anton is helping to unlock new insights into cellular mechanisms and disease pathways. Her achievements mark her as an innovator in the CRISPR toolkit space, and her continued efforts promise to further democratize high-throughput functional genomics for the broader research community.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays
10 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: AbbVie (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago